NPNestor Parolya

Nestor Parolya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nestor Parolya has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reviving pseudo-inverses: Asymptotic properties of large dimensional Moore–Penrose and ridge-type inverses with applications

    by Taras Bodnar, Nestor Parolya

    In this paper, we derive high-dimensional asymptotic properties of the Moore–Penrose inverse and, as a byproduct, of various ridge-type inverses of the sample covariance matrix. In particular, the analytical expressions of the asymptotic behavior of the weighted sample trace moments of generalized inverse matrices are deduced in terms of the partial exponential Bell polynomials, which can be easily computed in practice. The existent results for pseudo-inverses are extended in several directions: (i) First, the population covariance matrix is not assumed to be a multiple of the identity matrix; (ii) Second, the assumption of normality is not used in the derivation; (iii) Third, the asymptotic results are derived under the high-dimensional asymptotic regime. Our findings provide universal methodology for construction of fully data-driven improved shrinkage estimators of the precision matrix, optimal portfolio weights and beyond. It is found that the Moore–Penrose inverse acts asymptotically as a certain regularizer of the true covariance matrix and it seems that its proper transformation (shrinkage) performs similar to or even outperforms the existing benchmarks in many applications, while keeping the computational time as minimal as possible.

  • Reviving pseudo-inverses: Asymptotic properties of large dimensional Moore–Penrose and ridge-type inverses with applications

    by Taras Bodnar, Nestor Parolya

    In this paper, we derive high-dimensional asymptotic properties of the Moore–Penrose inverse and, as a byproduct, of various ridge-type inverses of the sample covariance matrix. In particular, the analytical expressions of the asymptotic behavior of the weighted sample trace moments of generalized inverse matrices are deduced in terms of the partial exponential Bell polynomials, which can be easily computed in practice. The existent results for pseudo-inverses are extended in several directions: (i) First, the population covariance matrix is not assumed to be a multiple of the identity matrix; (ii) Second, the assumption of normality is not used in the derivation; (iii) Third, the asymptotic results are derived under the high-dimensional asymptotic regime. Our findings provide universal methodology for construction of fully data-driven improved shrinkage estimators of the precision matrix, optimal portfolio weights and beyond. It is found that the Moore–Penrose inverse acts asymptotically as a certain regularizer of the true covariance matrix and it seems that its proper transformation (shrinkage) performs similar to or even outperforms the existing benchmarks in many applications, while keeping the computational time as minimal as possible.


  • Higher-order nonlinear shrinkage estimator of large-dimensional precision matrix

    by Taras Bodnar, Nestor Parolya

    This paper introduces a new type of nonlinear shrinkage estimators for the precision matrix in high-dimensional settings, where the dimension of the data-generating process exceeds the sample size. The proposed estimators incorporate the Moore–Penrose inverse and the ridge-type inverse of the sample covariance matrix, and they include linear shrinkage estimators as special cases. Recursive formulae of these higher-order nonlinear shrinkage estimators are derived using partial exponential Bell polynomials. Through simulation studies, the new methods are compared with the oracle nonlinear shrinkage estimator of the precision matrix for which no analytical expression is available.

  • Open Access

    Consistent estimation of the high-dimensional efficient frontier

    by Taras Bodnar, Nikolaus Hautsch, Yarema Okhrin, Nestor Parolya


  • Open Access

    High-Dimensional portfolio selection with HDShOP package

    by Taras Bodnar, Solomiia Dmytriv, Yarema Okhrin, Dmitry Otryakhin, Nestor Parolya


  • Open Access

    Consistent Estimation of the High-Dimensional Efficient Frontier

    by Taras Bodnar, Nikolaus Hautsch, Yarema Okhrin, Nestor Parolya

    In this paper, we analyze the asymptotic behavior of the main characteristics of the mean-variance efficient frontier employing random matrix theory. Our particular interest covers the case when the dimension $p$ and the sample size $n$ tend to infinity simultaneously and their ratio $p/n$ tends to a positive constant $c\in(0,1)$. We neither impose any distributional nor structural assumptions on the asset returns. For the developed theoretical framework, some regularity conditions, like the existence of the $4$th moments, are needed. It is shown that two out of three quantities of interest are biased and overestimated by their sample counterparts under the high-dimensional asymptotic regime. This becomes evident based on the asymptotic deterministic equivalents of the sample plug-in estimators. Using them we construct consistent estimators of the three characteristics of the efficient frontier. It it shown that the additive and/or the multiplicative biases of the sample estimates are solely functions of the concentration ratio $c$. Furthermore, the asymptotic normality of the considered estimators of the parameters of the efficient frontier is proved. Verifying the theoretical results based on an extensive simulation study we show that the proposed estimator for the efficient frontier is a valuable alternative to the sample estimator for high dimensional data. Finally, we present an empirical application, where we estimate the efficient frontier based on the stocks included in S\&P 500 index.


  • Open Access

    Nonlinear shrinkage test on a large‐dimensional covariance matrix

    by Taras Bodnar, Nestor Parolya, Frederik Veldman

    This paper is concerned with deriving a new test on a covariance matrix which is based on its nonlinear shrinkage estimator. The distribution of the test statistic is deduced under the null hypothesis in the large‐dimensional setting, that is, when with variables and samples both tending to infinity. The theoretical results are illustrated by means of an extensive simulation study where the new nonlinear shrinkage‐based test is compared with existing approaches, in particular with the commonly used corrected likelihood ratio test, the corrected John test, and the test based on the linear shrinkage approach. It is demonstrated that the new nonlinear shrinkage test possesses better power properties under heteroscedastic alternative.


  • Logarithmic law of large random correlation matrices

    by Nestor Parolya, Johannes Heiny, Dorota Kurowicka

    Consider a random vector y= Σ1∕2x, where the p elements of the vector x are i.i.d. real-valued random variables with zero mean and finite fourth moment, and Σ1∕2 is a deterministic p×p matrix such that the eigenvalues of the population correlation matrix R of y are uniformly bounded away from zero and infinity. In this paper, we find that the log determinant of the sample correlation matrix Rˆ based on a sample of size n from the distribution of y satisfies a CLT (central limit theorem) for p∕n→γ∈(0,1] and p≤n. Explicit formulas for the asymptotic mean and variance are provided. In case the mean of y is unknown, we show that after re-centering by the empirical mean the obtained CLT holds with a shift in the asymptotic mean. This result is of independent interest in both large dimensional random matrix theory and high-dimensional statistical literature of large sample correlation matrices for non-normal data. Finally, the obtained findings are applied for testing of uncorrelatedness of p random variables. Surprisingly, in the null case R=I, the test statistic becomes distribution-free and the extensive simulations show that the obtained CLT also holds if the moments of order four do not exist at all, which conjectures a promising and robust test statistic for heavy-tailed high-dimensional data.


  • Open Access

    Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models

    by André Wieringa, Tim M. J. Ewoldt, Ravish N. Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J. A. R. Kats, Isabel Spriet, Henrik Endeman, Jasper J. Haringman, Reinier M. van Hest, et al.

    In the intensive care unit (ICU), infection-related mortality is high. Although adequate antibiotic treatment is essential in infections, beta-lactam target non-attainment occurs in up to 45% of ICU patients, which is associated with a lower likelihood of clinical success. To optimize antibiotic treatment, we aimed to develop beta-lactam target non-attainment prediction models in ICU patients. Patients from two multicenter studies were included, with intravenous intermittent beta-lactam antibiotics administered and blood samples drawn within 12–36 h after antibiotic initiation. Beta-lactam target non-attainment models were developed and validated using random forest (RF), logistic regression (LR), and naïve Bayes (NB) models from 376 patients. External validation was performed on 150 ICU patients. We assessed performance by measuring discrimination, calibration, and net benefit at the default threshold probability of 0.20. Age, sex, serum creatinine, and type of beta-lactam antibiotic were found to be predictive of beta-lactam target non-attainment. In the external validation, the RF, LR, and NB models confirmed good discrimination with an area under the curve of 0.79 [95% CI 0.72–0.86], 0.80 [95% CI 0.73–0.87], and 0.75 [95% CI 0.67–0.82], respectively, and net benefit in the RF and LR models. We developed prediction models for beta-lactam target non-attainment within 12–36 h after antibiotic initiation in ICU patients. These online-accessible models use readily available patient variables and help optimize antibiotic treatment. The RF and LR models showed the best performance among the three models tested.